CNS effects of somatostatin (Q40167302)

18 September 2017

title

CNS effects of somatostatin (English)

1 reference

18 September 2017

4

1 reference

18 September 2017

1

Kastin AJ

1 reference

18 September 2017

2

Coy DH

1 reference

18 September 2017

Jacquet Y

3

1 reference

18 September 2017

Plotnikoff NP

series ordinal

5

1 reference

18 September 2017

publication date

1 September 1978

1 reference

18 September 2017

1 reference

18 September 2017

volume

27

1 reference

18 September 2017

issue

9 Suppl 1

1 reference

18 September 2017

page(s)

1247-1252

1 reference

Behavioural and motor excitation and inhibition induced by the administration of small and large doses of somatostatin into the amygdala☆

18 September 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

A radioimmunoassay for growth hormone release-inhibiting hormone: method and quantitative tissue distribution

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Depressant action of TRH, LH-RH and somatostatin on activity of central neurones

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Effect of somatostatin on calcium transport in guinea pig cortex synaptosomes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Identification by microinjection of TRH-sensitive sites in the cat's brain stem that mediate respiratory, temperature and other autonomic changes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Somatostatin in human cerebrospinal fluid

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

The Regional Distribution of Somatostatin in the Rat Brain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

“Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine Pancreas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Pancreatic somatostatinoma. Clinical features and physiological implications

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Central site of action of somatostatin (SRIF): role of hippocampus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Hypothalamic releasing factors: Physiological evidence for a regulatory action on central neurons and pathways for their distribution in brain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Cortical administration of somatostatin (SRIF): effect on sleep and motor behavior

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Central nervous system effects of hypothalamic peptides

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Cerebroventricular administration of somatostatin (SRIF): effect on central levels of cyclic AMP.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

MIF, TRH, and simian social and motor behavior

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Gonadotropin releasing hormone (GnRH): Neuropharmacological studies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Neuropharmacological actions of enkephalin after systemic administration

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Localization of growth hormone-release-inhibiting hormone (somatostatin) in the rat brain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

'Barrel rotation' induced by somatostatin in the non-lesioned rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Deserpidine Antagonism by a Tripeptide, L-Prolyl-L-Leucylglycinamide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Growth hormone release inhibiting hormone: neuropharmacological studies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Effect of hypophysectomy on hypothalamic somatostatin content in rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Neuropharmacological tests with alpha-melanocyte stimulating hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0026-0495(78)90053-7

Identifiers

DOI

10.1016/0026-0495(78)90053-7

1 reference

18 September 2017

1 reference